Cryosite Limited (CTE.AX) Comparison with companies in other sectors?

Cryosite Limited has a share price of 48.81M. You can analyze Cryosite Limited (CTE.AX) competitors across different market sectors through stock heatmaps.

What are CTE.AX's NET and operating margins?

Cryosite Limited (CTE.AX) operating margin is around 0.17, and net profit margin is approximately 0.14 as of the latest reports.

In what way does CTE.AX's earnings per share (EPS) trend reflect its financial momentum?

Cryosite Limited (CTE.AX) EPS is 0.04 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Cryosite Limited is 18.75, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Cryosite Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Cryosite Limited like P/E which is 19.98, P/B which is 27.92, and PEG which is -75.33. Compare them with sector averages to evaluate if the stock is priced fairly.

Cryosite Limited

CTE.AX•ASX

Healthcare

Medical - Diagnostics & Research

A$0.75

A$0.00(0.00%)

Cryosite Limited (CTE.AX) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$0.04

P/E Ratio

18.75

ROE

1.33%

Net Margin

0.14%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$36.61M

Shares OutstandingTotal number of shares issued

$48.81M

Book Value/ShareNet worth per share

$0.03

Revenue/ShareAnnual revenue per share

$0.26

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.04

Net MarginNet income as percentage of revenue

14.26%

Operating MarginOperating income as percentage of revenue

17.33%

ROEReturn on shareholders' equity

132.75%

ROAReturn on total assets

9.60%

ROCEReturn on capital employed

15.10%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.05

Cash/ShareCash and equivalents per share

$0.09

FCF YieldFree cash flow as percentage of market cap

6.02%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.07

Dividend YieldAnnual dividend as percentage of stock price

9.33%

Financial Ratios Analysis data is not available for CTE.AXFinancial Ratios Analysis details for CTE.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for CTE.AXSector Benchmarking details for CTE.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Cryosite Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Cryosite Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Cryosite Limited's unique business strengths and challenges.

Key Financial Metrics for Cryosite Limited

For Cryosite Limited, essential financial indicators include EPS 0.04, PE 18.75, and ROE 1.33. These key ratios reveal insights into Cryosite Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Cryosite Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Cryosite Limited

Metrics like Net Margin 14.26% and ROA 9.60% shed light on how well Cryosite Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Cryosite Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Cryosite Limited

Using ratios such as P/B Ratio 27.92 and PEG Ratio -75.33, investors can assess whether Cryosite Limited is appropriately valued based on its financials and growth potential. These figures, combined with Cryosite Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Cryosite Limited

Financial health indicators, such as Debt/Equity Ratio 1.80 and Cash Flow $0.05, provide a snapshot of Cryosite Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Cryosite Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Cryosite Limited

Investing in Cryosite Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Cryosite Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;